147 related articles for article (PubMed ID: 1854505)
21. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
Kornek GV; Depisch D; Rosen HR; Temsch EM; Scheithauer W
J Cancer Res Clin Oncol; 1992; 118(4):318-20. PubMed ID: 1374412
[TBL] [Abstract][Full Text] [Related]
22. A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B.
Stridsberg M; Eriksson B; Oberg K; Janson ET
Regul Pept; 2005 Feb; 125(1-3):193-9. PubMed ID: 15582732
[TBL] [Abstract][Full Text] [Related]
23. [Chromogranin A and neuroendocrine tumors].
Díaz Pérez JÁ; Currás Freixes M
Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
[TBL] [Abstract][Full Text] [Related]
24. Biochemical diagnosis of gastroenteropancreatic endocrine tumors.
Tartaglia A; Bianchini S; Vezzadini P
Minerva Med; 2003 Feb; 94(1):1-7. PubMed ID: 12719697
[TBL] [Abstract][Full Text] [Related]
25. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
26. CA 19-9: handle with care.
Galli C; Basso D; Plebani M
Clin Chem Lab Med; 2013 Jul; 51(7):1369-83. PubMed ID: 23370912
[TBL] [Abstract][Full Text] [Related]
27. Levels of carcinoembryonic antigen and carbohydrate antigen (CA19-9) in pure pancreatic juice and sera in a patient with occult pancreatic cancer.
Okai T; Sawabu N; Takemori Y; Ohta H; Motoo Y; Kidani H
J Clin Gastroenterol; 1992 Sep; 15(2):162-4. PubMed ID: 1401832
[No Abstract] [Full Text] [Related]
28. Is CA242 really a new tumour marker for pancreatic adenocarcinoma?
Plebani M; Basso D; Navaglia F; D'Angeli F; Panozzo MP; Del Giudice G; Battistel M; Meggiato T; Del Favero G
Oncology; 1995; 52(1):19-23. PubMed ID: 7800337
[TBL] [Abstract][Full Text] [Related]
29. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
Heptner G; Domschke S; Domschke W
Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
[TBL] [Abstract][Full Text] [Related]
30. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
31. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
32. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
van Dalen A; Kessler AC
Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
[TBL] [Abstract][Full Text] [Related]
33. A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A.
Stridsberg M; Eriksson B; Oberg K; Janson ET
Regul Pept; 2004 Mar; 117(3):219-27. PubMed ID: 14749043
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y
Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
Srivastava A; Hornick JL
Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
[TBL] [Abstract][Full Text] [Related]
36. Chromogranins--new sensitive markers for neuroendocrine tumors.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma.
Verdi CJ; Ahmann FR; Schifman RB; Elvick AL; Ahmann ME; Marx PC
Cancer; 1993 Jun; 71(11):3625-32. PubMed ID: 8490911
[TBL] [Abstract][Full Text] [Related]
38. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
[TBL] [Abstract][Full Text] [Related]
39. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
40. Various tumor markers for small pancreatic cancer with special reference to the present status of pancreatic cancer in Japan and our experience over the past 2 years.
Satake K; Chung YS; Yokomatsu H; Nakata B; Sawada T; Nishiwaki H; Umeyama K
Pancreas; 1991 Mar; 6(2):234-41. PubMed ID: 1886892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
